Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
59.9M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
18.3M
-
Shares change
-
+8.66M
-
Total reported value, excl. options
-
$48.2M
-
Value change
-
+$22.9M
-
Number of buys
-
21
-
Number of sells
-
-5
-
Price
-
$2.64
Significant Holders of Eledon Pharmaceuticals, Inc. - Common Stock (ELDN) as of Q2 2024
37 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock as of Q2 2024.
Eledon Pharmaceuticals, Inc. - Common Stock (ELDN) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.3M shares
of 59.9M outstanding shares and own 30.48% of the company stock.
Largest 10 shareholders include BVF INC/IL (6.29M shares), ARMISTICE CAPITAL, LLC (2.34M shares), Zimmer Partners, LP (2.11M shares), Schonfeld Strategic Advisors LLC (1.5M shares), SPHERA FUNDS MANAGEMENT LTD. (1.3M shares), VANGUARD GROUP INC (1.1M shares), Woodline Partners LP (675K shares), Nantahala Capital Management, LLC (600K shares), Alyeska Investment Group, L.P. (500K shares), and Ensign Peak Advisors, Inc (443K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.